A BILL 
To amend the Public Health Service Act to provide for 
the expansion, intensification, and coordination of the 
programs and activities of the National Institutes of 
Health with respect to Tourette syndrome. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Collaborative Academic 
4
Research Efforts for Tourette Syndrome Act of 2021’’. 
5
17:15 Jun 29, 2021
H3679
lotter on DSK11XQN23PROD with BILLS
2 
•HR 3679 IH
SEC. 2. PROGRAMS OF THE NATIONAL INSTITUTES OF 
1
HEALTH 
RELATING 
TO 
TOURETTE 
SYN-
2
DROME. 
3
Part B of title IV of the Public Health Service Act 
4
is amended by inserting after section 409J (42 U.S.C. 
5
284q) the following: 
6
‘‘SEC. 409K. EXPANSION, INTENSIFICATION, AND COORDI-
7
NATION OF ACTIVITIES WITH RESPECT TO 
8
TOURETTE SYNDROME. 
9
‘‘(a) IN GENERAL.—The Secretary, acting through 
10
the Director of NIH, shall expand, intensify, and coordi-
11
nate the programs and activities of the National Institutes 
12
of Health with respect to scientific and clinical research 
13
on Tourette syndrome. 
14
‘‘(b) DATA COLLECTION.— 
15
‘‘(1) SYSTEM.—In carrying out subsection (a), 
16
the Secretary shall develop a system to collect data 
17
on Tourette syndrome, including epidemiologic infor-
18
mation with respect to the incidence, prevalence, and 
19
impact of Tourette syndrome in the United States. 
20
‘‘(2) BROAD AND NARROW DEFINITIONS.—The 
21
data collection system under paragraph (1) shall 
22
provide for the collection of primary data on 
23
Tourette syndrome, including related data on the 
24
various conditions known to be comorbid with 
25
Tourette syndrome. 
26
17:15 Jun 29, 2021
H3679
lotter on DSK11XQN23PROD with BILLS
3 
•HR 3679 IH
‘‘(3) COLLECTION BY POPULATION AND GEO-
1
GRAPHICAL
REGION.—The data collection system 
2
under paragraph (1) shall provide for the collection 
3
of data on the availability of medical and social serv-
4
ices for individuals with Tourette syndrome and 
5
their families and the disaggregation of such data by 
6
population and geographical region. 
7
‘‘(c) COLLABORATIVE
RESEARCH
CENTERS
FOR 
8
TOURETTE SYNDROME.— 
9
‘‘(1) IN GENERAL.—In carrying out subsection 
10
(a), the Secretary shall award grants and contracts 
11
to public or nonprofit private entities to pay all or 
12
part of the cost of planning, establishing, improving, 
13
and providing basic operating support for Collabo-
14
rative Research Centers for Tourette Syndrome. 
15
‘‘(2) RESEARCH.—Each center under para-
16
graph (1) shall conduct basic and clinical research 
17
into Tourette syndrome. Such research should in-
18
clude investigations into the cause, diagnosis, early 
19
detection, prevention, control, and treatment of 
20
Tourette syndrome. The research conducted by such 
21
centers, as a group, shall include research in the 
22
fields of developmental neurobiology, neuroscience, 
23
genetics, psychology, and pharmacology. 
24
‘‘(3) SERVICES FOR PATIENTS.— 
25
17:15 Jun 29, 2021
H3679
lotter on DSK11XQN23PROD with BILLS
4 
•HR 3679 IH
‘‘(A) IN GENERAL.—A center under para-
1
graph (1) may expend amounts provided under 
2
such paragraph to carry out a program to make 
3
individuals aware of opportunities to participate 
4
as subjects in research conducted by the cen-
5
ters. 
6
‘‘(B) REFERRAL AND COSTS.—A program 
7
under subparagraph (A) may, in accordance 
8
with such criteria as the Secretary may estab-
9
lish, provide to the subjects described in such 
10
subparagraph, referrals for health and other 
11
services, and such patient care costs as are re-
12
quired for research. 
13
‘‘(C) AVAILABILITY AND ACCESS.—The ex-
14
tent to which a center can demonstrate avail-
15
ability and access to clinical services shall be 
16
considered by the Secretary in decisions about 
17
awarding grants and contracts to applicants 
18
which meet the scientific criteria for funding 
19
under this subsection. 
20
‘‘(4) ORGANIZATION
OF
COLLABORATIVE
RE-
21
SEARCH CENTERS FOR TOURETTE SYNDROME.— 
22
‘‘(A) IN GENERAL.—A center under para-
23
graph (1) may— 
24
17:15 Jun 29, 2021
H3679
lotter on DSK11XQN23PROD with BILLS
5 
•HR 3679 IH
‘‘(i) use the facilities of a single insti-
1
tution; or 
2
‘‘(ii) be formed from a consortium of 
3
cooperating institutions and patient advo-
4
cacy groups in order to maximize the scope 
5
of the center’s services and geographic cov-
6
erage. 
7
‘‘(B) ELIGIBILITY REQUIREMENTS.—To be 
8
eligible to make facilities so available (as de-
9
scribed in subparagraph (A)(i)) or participate 
10
in such a consortium (as described in subpara-
11
graph (A)(ii)), an institution or group shall 
12
meet such requirements as the Secretary may 
13
prescribe. 
14
‘‘(5) NUMBER OF CENTERS; DURATION OF SUP-
15
16
‘‘(A) IN GENERAL.—Subject to the avail-
17
ability of appropriations, the Secretary shall 
18
provide for the establishment of not fewer than 
19
4 and not more than 6 centers under paragraph 
20
(1). 
21
‘‘(B) GEOGRAPHICAL DISTRIBUTION.—The 
22
Secretary shall— 
23
‘‘(i) ensure that each of the centers 
24
established under paragraph (1) is located 
25
17:15 Jun 29, 2021
H3679
lotter on DSK11XQN23PROD with BILLS
6 
•HR 3679 IH
in a different region of the United States 
1
than other such centers; and 
2
‘‘(ii) encourage the formation of such 
3
centers from a consortium of entities (as 
4
described in paragraph (4)(A)(ii)) covering 
5
multiple regions or States. 
6
‘‘(C) DURATION.—Support for a center es-
7
tablished under paragraph (1) may be provided 
8
under this section for a period not to exceed 5 
9
years. Such period may be extended for one or 
10
more additional periods not exceeding 5 years if 
11
the operations of such center have been re-
12
viewed and approved by an appropriate tech-
13
nical and scientific peer review group estab-
14
lished by the Secretary and if such group has 
15
recommended to the Secretary that such period 
16
should be extended. 
17
‘‘(d) RESEARCH ON SYMPTOMOLOGY AND TREAT-
18
MENT.—In carrying out subsection (a), the Secretary shall 
19
award grants on a competitive, peer-reviewed basis for re-
20
search on— 
21
‘‘(1) the full range of symptomology within the 
22
Tourette syndrome clinical spectrum; and 
23
‘‘(2) the efficacy of treatment options for par-
24
ticular patient subpopulations. 
25
17:15 Jun 29, 2021
H3679
lotter on DSK11XQN23PROD with BILLS
7 
•HR 3679 IH
‘‘(e) FUNDING.—Of the amounts made available to 
1
carry out the programs and activities of the National In-
2
stitutes of Health for a fiscal year, the Secretary shall des-
3
ignate a portion of such amounts for carrying out the pro-
4
grams and activities of the National Institutes of Health 
5
with respect to Tourette syndrome.’’. 
6
Æ 
17:15 Jun 29, 2021
H3679
lotter on DSK11XQN23PROD with BILLS
